Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-010091

CHIEF FINANCIAL OFFICER gave up 514 shares (to pay taxes)

  • CHIEF FINANCIAL OFFICER acquired 1,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ragosa Mark CHIEF FINANCIAL OFFICER 2024-04-01 Option exercise +1,750 17,382 D
Ragosa Mark CHIEF FINANCIAL OFFICER 2024-04-01 Shares withheld for taxes −514 $19.70 $10,126 16,868 D
Derivatives
Ragosa Mark CHIEF FINANCIAL OFFICER 2024-04-01 Option exercise · Restricted Share Unit −1,750 5,250 D
Loading xslF345X05/form4-04032024_090446.xml…